Daniel Tasse
@danieltasse
Executive Officer, Director
Building DBV Technologies S.A. as Executive Officer, Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Alcresta, Inc. was founded in 2011 and has no closure on record.
Named alongside
- Alexey MargolinDirector
- Anastasios KonidarisExecutive Officer, Director
- Daniel OrlandoExecutive Officer, Director
- Eric FirstExecutive Officer
- Garheng KongDirector
- James GamgortExecutive Officer
- James TopperDirector
- Jeremy LackDirector
At Bellerophon Therapeutics, Inc.
- Adam B. WeinsteinDirector
- Adam WeinsteinDirector
- Amy A. EdmondsExecutive Officer
- Amy EdmondsVice President of Clinical Operations and Administration
- Andre MouraDirector
- Andre V. MouraDirector
- Daniel V. TasseDirector
- Deborah A. QuinnExecutive Officer
- Adora NduDirector
- Daniele Guyot-CaparrosDirector
- Daniel SolandDirector
- Julie O'NeillDirector
- Mailys FerrereDirector
- Michael GollerDirector
- Michel de RosenDirector
- Pharis MohideenExecutive Officer
Contribution
Daniel's ideas, decisions and failures appear here once this profile is claimed.
Companies
- DBV Technologies S.A.Biological Products, (No Diagnostic Substances); listed on Nasdaq as DBVT; filing with the SEC since 2014Executive Officer, Director · Pharmaceuticals · CHATILLON
- Alcresta, Inc.formerly Alcresta, Inc.; filing with the SEC since 2016Executive Officer, Director · Biotechnology · NEWTON, United States · Founded 2011
- Bellerophon Therapeutics, Inc.Pharmaceutical Preparations; formerly Bellerophon Therapeutics LLC; filing with the SEC since 2014Director · Pharmaceuticals · WARREN, United States · Founded 2015